article thumbnail

Buprenorphine Use in Serious Illness: A Podcast with Katie Fitzgerald Jones, Zachary Sager and Janet Ho

GeriPal

Janet: And so we have this whole spectrum of buprenorphine at these different doses that we should be able to utilize but people can feel limited just because of this X waiver policy to not fully access and be able to offer all of the medications. And the third step was transdermal buprenorphine at 10 micrograms. Nobody uses buprenorphine.

Illness 102
article thumbnail

FDA-Approved Labeling: Is Enough Enough?

FDA Law

Further, FDA has utilized a variety of strategies to call attention to safety issues through Dear Doctor letters or other forms of communication, even if directing changes to labeling is difficult. The same considerations ring true for OTC drugs. FDA, for years, has been concerned with overwarning.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Guiding an Improved Dementia Experience (GUIDE) Model: A Podcast with Malaz Boustani and Diane Ty

GeriPal

The typical utilization of inappropriate hospitalization and emergency room and total cost of care. So since 2008, we’ve been providing the service using our foundation money. And we have to actually co-design the goal of care with the patient and family, we have to write them down, we have to put the patient family first.

article thumbnail

Telemedicine in a Post-Pandemic World: Joe Rotella, Brooke Calton, Carly Zapata

GeriPal

And the Ryan Haight Act I think was passed in 2008, which was in response to a young person who died of an opioid overdose. We were the highest utilizers of telemedicine in the whole UCSF health system at that time which we’re very proud of. I think at least we like to think of ourselves as ahead of the curve.